Alzheimer's disease

The Pharmaceutical Benefits Scheme (PBS) subsidises medicines for eligible patients with Alzheimer's disease.

For patients with Alzheimer's disease, treatment with appropriate medicines is subsidised through the Pharmaceutical Benefits Scheme under section 85 of the National Health Act 1953.

Information on eligibility criteria can be found under the listed medications for Alzheimer’s disease on the PBS website. A valid prescription for each patient must also be submitted with an initial application form.

An Alzheimer disease PBS Initial authority application form (PB121) can be used for initial applications and for first continuing applications.

Lodging an application

Initial applications can be made by telephone or in writing. Initial telephone applications can only be made once per drug, for a maximum of up to 2 months' treatment.

Written applications can request up to 6 months' treatment.

Send all written applications to PBS authority approvals.

Further information

For more information contact us on the PBS authority approvals enquiry line.

Page last updated: 9 November 2016

This information was printed Friday 9 December 2016 from humanservices.gov.au/health-professionals/enablers/alzheimers-disease It may not include all of the relevant information on this topic. Please consider any relevant site notices at humanservices.gov.au/siteinformation when using this material.